Ariad Pharmaceuticals' Loss Shrinks 23% as Iclusig Revenue Rises

Ariad takes its first steps to rebuilding confidence with shareholders with a 23% reduction in losses heralded by a rise in Iclusig revenue and a reduction in R&D costs.

May 7, 2014 at 12:31PM

Controversial small-cap biopharmaceutical company Ariad Pharmaceuticals (NASDAQ:ARIA) took steps in the right direction to rebuilding its Iclusig brand this morning with the release of its first-quarter earnings results.

For the quarter, total revenue surged 82% to $11.8 million and included $8 million in sales of its leukemia drug Iclusig -- which was temporarily pulled from markets late last year for a couple of weeks and relabeled with more inclusive safety warnings – up 25% from the prior year. Per its press release, $4.7 million in sales came from the U.S. and $3.3 million from Europe. Ariad also noted $3.1 million in deferred revenue not yet reported, including $1.3 million in inventory waiting to be shipped from pharmacies to patients, and $1.8 million shipped to France despite the fact that reimbursement pricing negotiations are still ongoing.

In addition to product revenue, Ariad recorded $3.8 million in licensing revenue reflecting a $3.75 million milestone payment from Medinol for the licensing of ridaforolimus.

Research and development expenses shrank considerably during the quarter, partially as a result of the clinical hold placed on Iclusig by the FDA last year. R&D costs totaled just $28.6 million, down 31% from the prior-year period, as a reduction in clinical-trial costs, primarily the absence of its EPIC trial, which was shelved in October, led to the lower costs. Selling, general and administrative costs jumped 7% to $31.6 million and reflect the marketing effort put toward relaunching Iclusig at home and in new countries abroad.

Net loss for the quarter, inclusive of higher sales and lower costs, dipped 23% to $49.8 million, or $0.27 per share, from $64.7 million, or $0.36 per share in the year-ago period. Ariad announced that it ended the quarter with $183 million in cash and cash equivalents, down from $237.2 million in the sequential fourth quarter. 

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers